Neuraxial block, death and serious cardiovascular morbidity in the POISE trial†
نویسندگان
چکیده
K. Leslie1,2*, P. Myles4,5,7, P. Devereaux8,9,10, E. Williamson3,6, P. Rao-Melancini11, A. Forbes6, S. Xu12, P. Foex13, J. Pogue11, M. Arrieta14,15, G. Bryson16, J. Paul17, M. Paech18,19, R. Merchant20, P. Choi21,22, N. Badner23, P. Peyton24,25, J. Sear13 and H. Yang26 1 Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia 2 Department of Pharmacology and 3 School of Population Health, University of Melbourne, Melbourne, Australia 4 Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia 5 Academic Board of Anaesthesia and Perioperative Medicine and 6 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia 7 National Health and Medical Research Council Practitioner Fellow, Canberra, Australia 8 Department of Medicine, 9 Department of Clinical Epidemiology and 10 Department of Biostatistics, McMaster University, Hamilton, Canada 11 Population Health Research Institute, McMaster University, Hamilton, Canada 12 Fu Wai Cardiovascular Hospital, CAMS, Beijing, People’s Republic of China 13 Nuffield Department of Anaesthetics, Oxford University, Oxford, UK 14 Nueva Granada Military University, Bogota, Colombia 15 Department of Anaesthesia, Resuscitation and Pain Management, Central Military Hospital, Bogota, Colombia 16 Department of Anesthesiology, The Ottawa Hospital, Ottawa, Canada 17 Department of Anaesthesia, McMaster University, Hamilton Health Sciences, Hamilton, Canada 18 School of Medicine and Pharmacology, University of Western Australia, Perth, Australia 19 Department of Anaesthesia and Pain Medicine, King Edward Memorial Hospital for Women, Perth, Australia 20 Department of Anaesthesia and Perioperative Medicine, Royal Columbian Hospital, New Westminster, Canada 21 Department of Anesthesiology, Pharmacology and Therapeutics, 22 School of Population and Public Health, The University of British Columbia, Vancouver, Canada 23 Department of Anaesthesia and Perioperative Medicine, The University of British Columbia, Kelowna, Canada 24 Department of Anaesthesia, Austin Hospital, Melbourne, Australia 25 Department of Surgery, Austin Hospital and University of Melbourne, Melbourne, Australia 26 Department of Anaesthesia, University of Ottawa, Ottawa, Canada
منابع مشابه
Neuraxial block, death, and serious cardiovascular morbidity in the POISE trial.
BACKGROUND This post hoc analysis aimed to determine whether neuraxial block was associated with a composite of cardiovascular death, non-fatal myocardial infarction (MI) and non-fatal cardiac arrest within 30 days of randomization in POISE trial patients. METHODS A total of 8351 non-cardiac surgical patients at high risk of cardiovascular complications were randomized to β-blocker or placebo...
متن کاملRationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
BACKGROUND Noncardiac surgery is associated with significant cardiovascular mortality, morbidity, and cost. Small trials of beta-blockers suggest that they may prevent cardiovascular events in patients undergoing noncardiac surgery, but trial results are inconclusive. We have initiated the POISE trial to definitively establish the effects of beta-blocker therapy in patients undergoing noncardia...
متن کاملUnderstanding outcomes after neuraxial anaesthesia: time to turn the page.
For most of the last century, anaesthetists have debated the advantages and disadvantages of neuraxial block for patients undergoing major surgical procedures. While major clinical trials comparing outcomes with and without such techniques havenot been carried out since the early 2000s, 3 the anaesthesia literature has seen a proliferation of interest in this subject over the past 10 yr, as epi...
متن کاملRationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery.
BACKGROUND Worldwide, 200 million adults undergo major noncardiac surgery annually, and 10 million of these patients will have a major vascular complication. Low-dose clonidine and low-dose acetyl-salicylic acid (ASA) may prevent major perioperative vascular complications. We therefore initiated the POISE-2 trial to establish the perioperative effects of these 2 interventions. METHODS The POI...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013